Trial Details
RECRUITINGBasic Information
| Clinical ID | c802 |
|---|---|
| Identifier | NCT05782907 |
| Trial Title | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Upadacitinib |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-11-06 |
|---|---|
| Primary Completion Date | 2025-08-28 |
| Completion Date | - |